Acurx Pharmaceuticals (3ZO0) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ibezapolstat | Clostridium Difficile Infection Recurrence | Phase II | Recruiting | ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection | Mar 24, 2026 | ― |
| Vancomycin, Ibezapolstat | Clostridium Difficile Infection | Phase II | Completed | ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection | Jan 23, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ibezapolstat | Phase II | Clostridium Difficile Infection Recurrence | Recruiting | ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection | Mar 24, 2026 | ― |
| Vancomycin, Ibezapolstat | Phase II | Clostridium Difficile Infection | Completed | ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection | Jan 23, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Acurx Pharmaceuticals Llc (DE:3ZO0) have in its pipeline
Acurx Pharmaceuticals DE:3ZO0 is currently developing the following drugs: Ibezapolstat, Vancomycin, Ibezapolstat. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
